Concurrent Atezolizumab Plus Bevacizumab and High-Dose External Beam Radiotherapy for Highly Advanced Hepatocellular Carcinoma

CONCLUSIONS: The concurrent high-dose external beam radiotherapy appears to safely enhance the effectiveness of atezolizumab plus bevacizumab for highly advanced patients with HCC. Further studies are warranted to confirm these findings.PMID:38530254 | DOI:10.1093/oncolo/oyae048

Source: The Oncologist - March 26, 2024 Category: Cancer & Oncology Authors: Chung-Wei Su Wei Teng Eric Yi-Liang Shen Bing-Shen Huang Po-Ting Lin Ming-Mo Hou Tsung-Han Wu Din-Li Tsan Chia-Hsun Hsieh Ching-Ting Wang Pei-Mei Chai Chun-Yen Lin Shi-Ming Lin Chen-Chun Lin Source Type: research